• Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Thr599_Val600insThr (c.1794_1796dup) (p.Thr599dup); ClinVar=VCV000162793; Zygosity=Unspecified (PubMed=23658559).
  
• Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Heterozygous (PubMed=32567790).
  
• Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
  

PubMed=23658559; DOI=10.3389/fgene.2013.00066; PMCID=PMC3647113
Clare J. Stones, Ji Eun Kim, Wayne R. Joseph, Euphemia Yee Leung, Elaine S. Marshall, Graeme John Finlay, Andrew N. Shelling, Bruce Charles Baguley;
Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors.
Front. Genet. 4:66.1-66.6(2013)

PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249
Khanh B. Tran, Gregory Gimenez, Peter Tsai, Sharada Kolekar, Euan J. Rodger, Aniruddha Chatterjee, Anower Jabed, Jen-Hsing Shih, Wayne R. Joseph, Elaine S. Marshall, Qian Wang ...Show all 15 authors... , Cristin Gregor Print, Michael R. Eccles, Bruce Charles Baguley, Peter R. Shepherd; Show fewer authors
Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: a valuable model for studying the impact of genetic diversity in melanoma.
Pigment Cell Melanoma Res. 34:136-143(2021)